New i-On Skincare Creams Provide Clinically-Proven De-Ironizing Inducer Technology
DII technology is designed to remove excess iron from the skin and prevent free radicals from forming—which can cause the skin to age.
DII technology is designed to remove excess iron from the skin and prevent free radicals from forming—which can cause the skin to age.
Midpoint data from a 10-year clinical study show low rates of reoperation, rupture, and capsular contracture in primary augmentation patients.
Researchers have discovered a naturally occurring protein that could lead to new therapies for preventing excessive scarring in patients during wound healing.
A peer reviewed journal article highlighting the efficacy and safety of prabotulinumtoxinA (Jeuveau) for the treatment of moderate to severe glabellar lines, also known as frown lines between the eyes, in adult patients with Skin of Color (SOC), was published recently in Dermatologic Surgery, Evolus Inc announces in a media release.
Read MoreXtalks hosts Developing a Digital Protocol for Dermatology Trials: A Step-by-Step Guide to Optimizing Research for Patients and Clinicians, Friday December 4, 2020, at 10 am EST.
Read MoreBased on encouraging safety and long-term efficacy results of the Dysport study, and continued patient satisfaction, the company is evaluating future clinical studies.
Read MoreSoftWave Tissue Regeneration Technologies announces its plan to embark on a 60-patient study for the treatment of cellulite.
Read MoreA free webinar hosted by Xtalks participants will feature a discussion about Hybrid/Virtual trials in the clinical research space and technological advances in mobile health platforms in dermatology clinical trials.
Read MorePulse Biosciences Inc announces that three clinical studies demonstrating positive results across its dermatologic portfolio are available via webcast at the virtual annual conference of the American Society for Laser Medicine and Surgery (ASLMS).
Read More